Meta Platforms Chief Product Officer Cox Christopher K. sold 20,000 shares in two transactions on Sep. 9, 2026, at prices from $650.21 to $651.15 per share. The transaction matters to investors because Cox retained 244,516 Meta Platforms shares after the sales, while the reported S code identifies each transaction as a sale.
Key Highlights
- The two Meta Platforms transactions were priced between $650.21 and $651.15 per share.
- Cox Christopher K. retained 244,516 Meta Platforms shares after the transactions.
- Both transactions carried the SEC transaction code S, identifying them as sales.
Meta Platforms, Inc (NASDAQ: META). Chief Product Officer Cox Christopher K. sold 20,000 shares in two transactions on Sep. 9, 2026. Cox retained 244,516 Meta Platforms shares after the activity.
Two Sales Priced Up to $651.15
The reported prices ranged from $650.21 to $651.15 per share. Both transactions involved shares of Meta Platforms, Inc. and were attributed to Cox Christopher K. in his role as Chief Product Officer. The post-transaction position was recorded at 244,516 shares. The disclosed activity comprised two separate sales completed on Sep. 9, 2026.
FAQs
Q: What did Cox Christopher K. sell in the Meta Platforms insider transaction?
A: Cox Christopher K. sold 20,000 Meta Platforms shares across two transactions on Sep. 9, 2026. The prices ranged from $650.21 to $651.15 per share.
Q: How many Meta Platforms shares does Cox Christopher K. own after the sale?
A: Cox Christopher K. held 244,516 Meta Platforms shares after the transactions. He is identified as Meta Platforms’ Chief Product Officer.
Q: What does transaction code S mean for Meta Platforms shares?
A: The article identifies the activity as two sales involving 20,000 Meta Platforms shares sold by Cox Christopher K. The sales were completed on Sep. 9, 2026, after which he retained 244,516 shares.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.